Research Papers:
Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1200 views | HTML 1978 views | ?
Abstract
Hongying Zhao1,*, Huating Yuan1,*, Jing Hu1,*, Chaohan Xu1,*, Gaoming Liao1, Wenkang Yin1, Liwen Xu1, Li Wang1, Xinxin Zhang1, Aiai Shi1, Jing Li2 and Yun Xiao1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China
2Department of Ultrasonic Medicine, The 1st Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China
*These authors have contributed equally to this work
Correspondence to:
Yun Xiao, email: [email protected]
Jing Li, email: [email protected]
Keywords: miRNA; key miRNA-target interactions; prognosis; cancer metastasis; human cancers
Received: May 24, 2017 Accepted: July 26, 2017 Published: November 27, 2017
ABSTRACT
Increasing evidence suggests that the abnormality of microRNAs (miRNAs) and their downstream targets is frequently implicated in the pathogenesis of human cancers, however, the clinical benefit of causal miRNA-target interactions has been seldom studied. Here, we proposed a computational method to optimize prognosis-related key miRNA-target interactions by combining transcriptome and clinical data from thousands of TCGA tumors across 16 cancer types. We obtained a total of 1,956 prognosis-related key miRNA-target interactions between 112 miRNAs and 1,443 their targets. Interestingly, these key target genes are specifically involved in tumor progression-related functions, such as ‘cell adhesion’ and ‘cell migration’. Furthermore, they are most significantly correlated with ‘tissue invasion and metastasis’, a hallmark of metastasis, in ten distinct types of cancer through the hallmark analysis. These results implicated that the prognosis-related key miRNA-target interactions were highly associated with cancer metastasis. Finally, we observed that the combination of these key miRNA-target interactions allowed to distinguish patients with good prognosis from those with poor prognosis both in most TCGA cancer types and independent validation sets, highlighting their roles in cancer metastasis. We provided a user-friendly database named miRNATarget (freely available at http://biocc.hrbmu.edu.cn/miRNATar/), which provides an overview of the prognosis-related key miRNA-target interactions across 16 cancer types.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22724